BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7863274)

  • 21. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    McCarthy EM; MacMullan PA; Al-Mudhaffer S; Madigan A; Donnelly S; McCarthy CJ; Molloy ES; Kenny D; McCarthy GM
    J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.
    Cutolo M; Montecucco CM; Cavagna L; Caporali R; Capellino S; Montagna P; Fazzuoli L; Villaggio B; Seriolo B; Sulli A
    Ann Rheum Dis; 2006 Nov; 65(11):1438-43. PubMed ID: 16644782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica.
    Schreiber S; Buyse M
    Clin Rheumatol; 1995 May; 14(3):315-8. PubMed ID: 7641508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
    J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica.
    Pulsatelli L; Meliconi R; Boiardi L; Macchioni P; Salvarani C; Facchini A
    Clin Exp Rheumatol; 1998; 16(3):263-8. PubMed ID: 9631747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment.
    Pirro M; Bocci EB; Di Filippo F; Schillaci G; Mannarino MR; Bagaglia F; Gerli R; Mannarino E
    J Intern Med; 2012 Aug; 272(2):177-84. PubMed ID: 22211720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica.
    Carvajal Alegria G; Devauchelle-Pensec V; Renaudineau Y; Saraux A; Pers JO; Cornec D
    Rheumatology (Oxford); 2017 Aug; 56(8):1401-1406. PubMed ID: 28431111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.
    Uddhammar A; Rantapåå-Dahlqvist S; Nilsson TK
    Clin Rheumatol; 1992 Jun; 11(2):211-5. PubMed ID: 1617895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
    Devauchelle-Pensec V; Saraux L; Berthelot JM; De Bandt M; Cornec D; Guellec D; Marhadour T; Jousse-Joulin S; Gouillou M; Saraux A
    Rheumatology (Oxford); 2018 Apr; 57(4):666-670. PubMed ID: 29346621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.
    Galbo H; Kall L
    Arthritis Res Ther; 2016 Jul; 18(1):174. PubMed ID: 27455959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
    Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
    Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the relationship between polymyalgia rheumatica and matrix metalloproteinase-3 levels during the first medical examination and during treatment].
    Miyake K; Katsuyama T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(1):48-54. PubMed ID: 24598068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment.
    Meliconi R; Pulsatelli L; Uguccioni M; Salvarani C; Macchioni P; Melchiorri C; Focherini MC; Frizziero L; Facchini A
    Arthritis Rheum; 1996 Jul; 39(7):1199-207. PubMed ID: 8670331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica.
    Gabriel SE; Sunku J; Salvarani C; O'Fallon WM; Hunder GG
    Arthritis Rheum; 1997 Oct; 40(10):1873-8. PubMed ID: 9336424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term treatment of polymyalgia rheumatica with deflazacort.
    Cimmino MA; Moggiana G; Montecucco C; Caporali R; Accardo S
    Ann Rheum Dis; 1994 May; 53(5):331-3. PubMed ID: 8017988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.
    Grau RG; Kassan SS; Franks JJ; Kaplan H; Walker SH; Tan EM
    Ann Rheum Dis; 1984 Oct; 43(5):721-4. PubMed ID: 6497463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.